Rigel Pharmaceuticals
RIGL
107 hedge funds and large institutions have $210M invested in Rigel Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 42 reducing their positions, and 27 closing their positions.
8.92% more ownership
Funds ownership: 0% → 8.92% (+8.9%)
12% less funds holding
Funds holding: 121 → 107 (-14)
23% less call options, than puts
Call options by funds: $202K | Put options by funds: $262K
26% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 42
33% less capital invested
Capital invested by funds: $316M → $210M (-$105M)
48% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$4.96M |
| 2 |
SAM
Senzar Asset Management
New York
|
-$3.33M |
| 3 |
Goldman Sachs
New York
|
-$3.3M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$2.89M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$2.55M |
RIGL Hedge Fund Activity: Q4 2016 in Review
107 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2016, worth a combined $210M — down 33% from $316M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of RIGL and 14 opened new positions — a net loss of 13 holders — while 42 trimmed existing stakes and 31 added.
The largest buyer was Wellington Management Group, adding an estimated $16.5M. The largest seller was Boxer Capital, exiting entirely with an estimated $4.96M sold.
- 107 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2016, down from 121 in Q3 2016.
- Funds reported $210M of Rigel Pharmaceuticals stock for Q4 2016, down 33% quarter-over-quarter.
- 14 funds opened new Rigel Pharmaceuticals positions in Q4 2016 and 27 closed out, a net change of -13 holders.
- The largest Rigel Pharmaceuticals buyer in Q4 2016 was Wellington Management Group, an estimated $16.5M added.
- The largest Rigel Pharmaceuticals seller in Q4 2016 was Boxer Capital, an estimated $4.96M sold.
Based on aggregated 13F filings for Q4 2016.